T1	Participants 0 110	Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog:
T2	Participants 218 270	short children born small for gestational age (SGA).
T3	Participants 767 778	expectation
T4	Participants 861 923	included 121 short SGA children (60 boys) at least 8 yr of age
T5	Participants 928 1040	performed intention-to-treat analyses on all children and uncensored case analyses on 84 children who reached AH
T6	Participants 1227 1253	RESULTS Short SGA children
T7	Participants 1916 1989	in short SGA children, particularly with GH 2 mg/m(2) Â· d during puberty
